[HTML][HTML] Three-dimensional modelling of ovarian cancer: From cell lines to organoids for discovery and personalized medicine

C Yee, KA Dickson, MN Muntasir, Y Ma… - … in Bioengineering and …, 2022 - frontiersin.org
Ovarian cancer has the highest mortality of all of the gynecological malignancies. There are
several distinct histotypes of this malignancy characterized by specific molecular events and …

In vitro veritas: from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment

DV Krysko, R Demuynck, I Efimova, F Naessens… - Cells, 2022 - mdpi.com
Immunogenic cell death (ICD) is a functionally unique form of cell death that promotes a T-
cell-dependent anti-tumor immune response specific to antigens originating from dying …

[HTML][HTML] Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer

S Hofmann, R Cohen-Harazi, Y Maizels… - Translational cancer …, 2022 - ncbi.nlm.nih.gov
Background Breast cancer is the most common cause of cancer related deaths in women.
Treatment of breast cancer has many limitations including a lack of accurate biomarkers to …

Screening of dual chemo-photothermal cellular nanotherapies in organotypic breast cancer 3D spheroids

LP Ferreira, VM Gaspar, MV Monteiro, B Freitas… - Journal of Controlled …, 2021 - Elsevier
Living therapeutics approaches that exploit mesenchymal stem cells (MSCs) as
nanomedicine carriers are highly attractive due to MSCs native tropism toward the 3D tumor …

A framework for optimizing high-content imaging of 3D models for drug discovery

J Wardwell-Swanson, M Suzuki… - … the Science of Drug …, 2020 - journals.sagepub.com
Three-dimensional (3D) spheroid models are rapidly gaining favor for drug discovery
applications due to their improved morphological characteristics, cellular complexity, long …

Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches

A Van Rijt, E Stefanek, K Valente - Cancers, 2023 - mdpi.com
Simple Summary Traditional preclinical testing, including 2D cell culture and animal models,
often fails to accurately predict drug efficacy in humans, especially for oncology drugs …

Engineering stromal heterogeneity in cancer

LJW Tang, A Zaseela, CCM Toh, C Adine… - Advanced Drug Delivery …, 2021 - Elsevier
Based on our exponentially increasing knowledge of stromal heterogeneity from advances
in single-cell technologies, the notion that stromal cell types exist as a spectrum of unique …

[HTML][HTML] Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast …

H Axemaker, S Plesselova, K Calar… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Cancer-associated fibroblasts (CAFs) are key contributors to ovarian cancer (OC)
progression and therapeutic resistance through dysregulation of the extracellular matrix …

High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment

B Calpe, WJ Kovacs - Expert opinion on drug discovery, 2020 - Taylor & Francis
Introduction Solid tumors are highly influenced by a complex tumor microenvironment (TME)
that cannot be modeled with conventional two-dimensional (2D) cell culture. In addition …

[HTML][HTML] Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells

H Mazuelas, M Carrió, E Serra - Stem Cell Research, 2020 - Elsevier
Plexiform neurofibromas (pNFs) are benign tumors of the peripheral nervous system (PNS)
that can progress towards a deadly soft tissue sarcoma termed malignant peripheral nerve …